JOURNAL 2705


Organic Communications
VOLUME & ISSUE
Year: 2023 Issue: 1 January-March
PAGES
p.24 - 34
STATISTICS
Viewed 820 times.
AUTHORS
  • Tugce Gur Maz
  • Huseyin Burak Caliskan
PDF OF ARTICLE

GRAPHICAL ABSTRACT


ABSTRACT


Inhibition of soluble epoxide hydrolase (sEH) is implicated as a new therapeutic approach against inflammatory disorders in the context of metabolic and cardiovascular diseases. In the course of our ongoing research on sEH inhibitors, we synthesized novel piperididine/piperazine amide derivatives of the chromone-2-carboxylic acid, and evaluated their inhibitory properties against human sEH. The chemical structures of the target compounds (2-5, 7-9) were elucidated by means of 1H-NMR, 13C-NMR and HRMS spectra. Initial screening of final compounds against sEH at a final concentration of 10 micromolar led to the identification of compound 7, which inhibited sEH activity in a concentration-dependent manner with an IC50 = 1.75 m​​​​​icromolar. Therefore, this chromen-2-amide derivative 7 decorated with benzyl piperidine on the amide side can be regarded as a novel lead structure, which pave the way of developing new analogues with improved inhibitory activities against sEH.

KEYWORDS
  • fluorometric
  • inhibition
  • piperazine
  • piperidine
  • soluble epoxide hydrolase

SUPPORTING INFORMATION


Supporting Information
Download File A3-145-OC-2302-2705-SI.pdf (2.36 MB)